News overview


Saved filters

To save filters, please log in.

Sorting
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer
11.11.2026 18:06

MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for adults with squamous cell carcinoma of the anal canal.

United Kingdom
CMA – Competition and Markets Authority
Unknown author
Industry, Pharmaceutical industry, Healthcare, Healthcare and hospitals
Sorting